Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

NCT00006379 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
58
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Case Comprehensive Cancer Center

Collaborators